[Ecology and mechanisms of bacterial resistance to antibiotics in peritonitis]

Anita Edern1, Marguerite Fines-Guyon, Cindy Castrale

  • 1Service de néphrologie-dialyse-transplantation rénale, CHU Clémenceau, avenue G.-Clémenceau, 14033 Caen cedex, France.

Nephrologie & Therapeutique
|February 14, 2012
PubMed

Insights

Antibiotic resistance in peritoneal dialysis peritonitis is common, especially with Staphylococci. Current International Society for Peritoneal Dialysis (ISPD) guidelines are effective for most bacteria but require adjustment for Staphylococcal strains producing PBP2a, necessitating vancomycin treatment.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Microbiology

Context:

  • Peritonitis is a frequent complication in patients undergoing peritoneal dialysis.
  • Understanding antibiotic resistance mechanisms is crucial for effective treatment.
  • International Society for Peritoneal Dialysis (ISPD) guidelines provide a framework for peritonitis management.

Purpose:

  • To investigate antibiotic resistance mechanisms in bacteria causing peritonitis in peritoneal dialysis patients.
  • To evaluate the suitability of ISPD-recommended antibiotic therapy against identified resistance mechanisms.

Summary:

  • A review of 170 peritonitis episodes in 106 dialysis patients (2005-2010) identified common microorganisms.
  • Coagulase-negative staphylococci (73 isolates) and Enterobacteriaceae (45 isolates) were most frequent.
  • While Enterobacteriaceae were largely susceptible to third-generation cephalosporins, exceptions included ESBL or cephalosporinase producers. Staphylococci, particularly those with PBP2a (46 isolates), showed resistance to first-generation cephalosporins.

Impact:

  • ISPD antibiotic therapy is effective for most peritonitis-causing bacteria, except for certain staphylococcal strains.
  • The presence of PBP2a in staphylococci necessitates alternative treatment strategies.
  • Vancomycin is recommended for peritonitis cases involving staphylococcus strains producing PBP2a, ensuring appropriate patient management.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...